617MO Safety and tolerability of INCB123667, a selective CDK2 inhibitor, in patients (pts) with advanced solid tumors: A phase I study

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 35; p. S495
Main Authors Simonelli, M., Lorusso, D., Homicsko, K., Seguy, F., Kinder, M., Liu, Q., Croft, E., Kitano, S.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2024
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2024.08.684